Stocktoria
MIMEDX GROUP, INC. MDXG
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2007-08-20
MIMEDX GROUP, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $418.6M | $348.9M | $321.5M | $267.8M | $242.0M |
| Gross profit | $345.6M | $288.8M | $266.8M | $219.5M | $202.4M |
| R&D expense | $15.1M | $12.3M | $12.7M | $12.7M | $9.9M |
| SG&A expense | $266.2M | $225.1M | $211.1M | $208.7M | $194.8M |
| Operating income | $63.9M | $58.9M | $37.1M | -$14.7M | -$7.1M |
| Income tax | $17.7M | $15.3M | -$36.8M | $206,000 | $247,000 |
| Net income | $48.6M | $42.4M | $58.2M | -$30.2M | -$10.3M |
| EPS (diluted) | $0.32 | $0.28 | $0.37 | $-0.33 | $-0.15 |
| Operating cash flow | $74.0M | $67.1M | $34.9M | -$17.9M | -$9.9M |
| Free cash flow | — | — | $33.0M | -$19.4M | -$13.1M |
| Cash & equivalents | $166.1M | $104.4M | $82.0M | $66.0M | $87.1M |
| Inventory | $25.3M | $23.8M | $21.0M | $13.2M | $11.4M |
| Total assets | $342.7M | $263.9M | $239.0M | $171.4M | $187.9M |
| Total liabilities | $86.1M | $70.8M | $96.3M | $96.9M | $95.4M |
| Shareholders' equity | $256.5M | $193.1M | $142.7M | -$18.0M | $82,000 |
Source: SEC EDGAR filings · CIK 0001376339 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.